{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:03:16Z","timestamp":1769803396144,"version":"3.49.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The epidemiological profile of non-alcoholic fatty liver disease (NAFLD) in Wenshan City, a southwestern Chinese city with a population of 3.4 million, is not well-defined. This study aimed to examine the prevalence of NAFLD and its risk factors among healthy adults in Wenshan City.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 11,997 individuals who underwent health checkups at the People's Hospital of Wenshan Prefecture in 2022. Of these, 6,419 eligible adult subjects were analyzed. Each participant received abdominal ultrasonography and laboratory tests. Statistical analysis using R language was conducted to compare NAFLD prevalence, estimate odds ratios for NAFLD risk factors via logistic regression, and examine correlations between NAFLD and factors like age and gender. Additionally, the relationship between NAFLD, hyperlipidemia, liver injury, and the combination of hyperlipidemia and liver injury was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 6,419 patients studied, the average age was 44.8 years (SD\u2009=\u200914.1), with a gender distribution of 59.4% males (3,815) and 40.6% females (2,604). The overall prevalence of NAFLD was 33.3% (2,138\/6,419), with 39.6% (1,511\/3,815) in males and 24.1% (627\/2,604) in females. The average age of NAFLD patients was 47.9\u2009\u00b1\u200913.3 years, with a tendency to rise as age increased. The study found a high prevalence of hyperlipidemia (40.4%), liver injury (32.3%), and their combination (17.3%) in Wenshan adults, with higher rates in males than females. Prevalence increased with age until 60, after which it declined in males but rose in females for NAFLD. In the NAFLD population, hyperlipidemia was prevalent in 63.9% (69.1% males, 51.5% females), liver injury in 43.4% (51.0% males, 25.2% females), and both conditions in 31.3% (38.3% males, 14.4% females).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings highlight significant associations between fatty liver, gender, age, and related health conditions. This finding suggests that special attention should be given to the prevention and management of NAFLD in border regions and integrated management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1571261","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:42:55Z","timestamp":1769755375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cross-sectional analysis of adult fatty liver prevalence in Wenshan, China: an epidemiologic study using ultrasound and laboratory assessments"],"prefix":"10.3389","volume":"13","author":[{"given":"Guangpin","family":"Zeng","sequence":"first","affiliation":[{"name":"Quality Control Department, The People's Hospital of Wenshan Prefecture","place":["Wenshan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghong","family":"Li","sequence":"additional","affiliation":[{"name":"General Practice, People's Hospital of Wenshan Prefecture","place":["Wenshan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghong","family":"Lin","sequence":"additional","affiliation":[{"name":"General Practice, People's Hospital of Wenshan Prefecture","place":["Wenshan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoude","family":"Yang","sequence":"additional","affiliation":[{"name":"General Practice, People's Hospital of Wenshan Prefecture","place":["Wenshan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linran","family":"Zeng","sequence":"additional","affiliation":[{"name":"Geriatrics and Gastroenterology Department, The First Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.3748\/wjg.v21.i18.5695","article-title":"Prevalence of fatty liver disease and the economy in China: a systematic review","volume":"21","author":"Zhu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s42779-021-00087-3","article-title":"Analysis of the health effects of the transition of traditional Chinese food on the emergence of nontraditional eating behaviors","volume":"8","author":"Halawa","year":"2021","journal-title":"J Ethn Foods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.3390\/nu15183997","article-title":"Sugar-sweetened beverages and artificially sweetened beverages consumption and the risk of nonalcoholic fatty liver (NAFLD) and nonalcoholic steatohepatitis (NASH)","volume":"15","author":"Tseng","year":"2023","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/nu8090527","article-title":"Associations between dietary nutrient intakes and hepatic lipid contents in NAFLD patients quantified by (1)H-MRS and dual-Echo MRI","volume":"8","author":"Cheng","year":"2016","journal-title":"Nutrients"},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/biomedicines12040826","article-title":"Nafld in the 21st century: current knowledge regarding its pathogenesis, diagnosis and therapeutics","volume":"12","author":"Kounatidis","year":"2024","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/MEG.0000000000001235","article-title":"Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies","volume":"30","author":"Tomic","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of disease due to nonalcoholic fatty liver disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","author":"Mantovani","year":"2020","journal-title":"Metab Clin Exp"},{"key":"B18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12664-020-01018-x","article-title":"Epidemiology of non-alcoholic fatty liver disease in Asia","volume":"39","author":"Wong","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1089\/dia.2020.2513","article-title":"Nafld\/NASH and diabetes","volume":"22","author":"Garg","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1127489","DOI":"10.3389\/fpubh.2023.1127489","article-title":"Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: a cross-sectional study in Chongqing, China","volume":"11","author":"Kong","year":"2023","journal-title":"Front Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-10-8684-7_2","article-title":"Epidemiology and etiologic associations of non-alcoholic fatty liver disease and associated HCC","volume":"1061","author":"Liu","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian Perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1047129","DOI":"10.3389\/fnut.2022.1047129","article-title":"Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: a systematic analysis of the global burden of disease study 2019","volume":"9","author":"Wang","year":"2022","journal-title":"Front Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1200\/EDBK_200939","article-title":"Global epidemiology, prevention, and management of hepatocellular carcinoma","volume":"38","author":"Mak","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jceh.2022.12.005","article-title":"The growing economic and clinical burden of nonalcoholic steatohepatitis (NASH) in the United States","volume":"13","author":"Younossi","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/hepr.13535","article-title":"Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: data from Hong Kong","volume":"50","author":"Tampi","year":"2020","journal-title":"Hepatol Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cld.2023.01.007","article-title":"Economic burden and patient-reported outcomes of nonalcoholic fatty liver disease","volume":"27","author":"Stepanova","year":"2023","journal-title":"Clin Liver Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cgh.2016.07.020","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","volume":"15","author":"Stepanova","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","article-title":"Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases","volume":"9","author":"Zeng","year":"2008","journal-title":"J Dig Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.11909\/j.issn.1671-5411.2018.01.011","article-title":"Chinese Guidelines for the management of dyslipidemia in adults","volume":"15","year":"2016","journal-title":"J. Geriatr. Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3760\/cma.j.cn501113-20240327-00163","article-title":"Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (version 2024)","volume":"32","year":"2024","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7%3C539::AID-DIA668%3E3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751","article-title":"Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)","volume":"61","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3760\/cma.j.cn112138-20200505-00449","article-title":", practice guideline for patients with hyperuricemia\/gout","volume":"59","author":"Huang","year":"2020","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/DMSO.S80364","article-title":"Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study","volume":"8","author":"Lesmana","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/hep.21248","article-title":"Statins and hepatic steatosis: perspectives from the Dallas heart study","volume":"44","author":"Browning","year":"2006","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0171502","DOI":"10.1371\/journal.pone.0171502","article-title":"Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort","volume":"12","author":"van den Berg","year":"2017","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4415\/ANN_17_01_14","article-title":"Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in southern Italy","volume":"53","author":"Caserta","year":"2017","journal-title":"Ann Ist Super Sanita"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2023.06.008","article-title":"China\u2019s fatty liver crisis: a looming public health emergency","volume":"165","author":"Yip","year":"2023","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of liver steatosis and fibrosis in the general population and Various high-risk populations: a nationwide study with 5.7 million adults in China","volume":"165","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"B53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J Hepatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0021","DOI":"10.1097\/MD.0000000000010021","article-title":"Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-230X-12-123","article-title":"Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units","volume":"12","author":"Hu","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J Gastroenterol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e3156","DOI":"10.1002\/dmrr.3156","article-title":"Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort","volume":"35","author":"Zhou","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.14218\/JCTH.2020.00027","article-title":"Hypothyroidism and nonalcoholic fatty liver disease: pathophysiological associations and therapeutic implications","volume":"8","author":"Kizivat","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/09513590.2013.875992","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women","volume":"30","author":"Rodrigues","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e37094","DOI":"10.7759\/cureus.37094","article-title":"Non-alcoholic fatty liver disease in overt hypothyroidism: a cross-sectional study in a tertiary care hospital","volume":"15","author":"Augustine","year":"2023","journal-title":"Cureus"},{"key":"B64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/jmwh.13637","article-title":"Hyperlipidemia prevention and management utilizing lifestyle changes","volume":"69","author":"Giles","year":"2024","journal-title":"J Midwifery Womens Health"},{"key":"B65","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.plipres.2021.101109","article-title":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","volume":"83","author":"Li","year":"2021","journal-title":"Prog Lipid Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1054159","DOI":"10.3389\/fimmu.2022.1054159","article-title":"Association of complement components with the risk and severity of NAFLD: a systematic review and meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.athplu.2023.08.001","article-title":"High-density lipoproteins and non-alcoholic fatty liver disease","volume":"53","author":"Hoekstra","year":"2023","journal-title":"Atheroscler Plus"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1457598","DOI":"10.3389\/fendo.2024.1457598","article-title":"Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States","volume":"15","author":"Xuan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"Hdl cholesterol: reappraisal of its clinical relevance","volume":"106","author":"M\u00e4rz","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cgh.2012.03.011","article-title":"Features, diagnosis, and treatment of nonalcoholic fatty liver disease","volume":"10","author":"Torres","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12876-021-01790-w","article-title":"Normalization of gamma-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B73","first-page":"603","article-title":"Nonalcoholic fatty liver disease: common questions and answers on diagnosis and management","volume":"102","author":"Westfall","year":"2020","journal-title":"Am Fam Physician"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B75","first-page":"167","article-title":"Pathogenesis and prevention of hepatic steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults","volume":"40","author":"Chen","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"Aisf position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","author":"Lonardo","year":"2017","journal-title":"Dig Liver Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study","volume":"108","author":"Xu","year":"2013","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1571261\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:43:00Z","timestamp":1769755380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1571261\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":78,"alternative-id":["10.3389\/fcvm.2026.1571261"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1571261","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1571261"}}